Bayer AG (BAYZF) Stock Research, Analysis & News

Quick Analysis on Bayer AG (BAYZF) Stock as of August 24, 2019

The Stock pays no dividend
Average trading volume is relatively low at 0
(See more information about Bayer AG (BAYZF) Stock below)

Bayer AG (BAYZF) Stock Profile Summary

Bayer AG develops, produces, and markets pharmaceuticals and health care products, agricultural products, and specialty materials worldwide. The companys Pharmaceuticals segment provides prescription pharmaceuticals to treat hypertension, cardiovascular and infectious diseases, cancer, multiple sclerosis, and contraception, as well as contrast media for use in diagnostic imaging. Its Consumer Health segment offers over-the-counter medications, dermatology products, nutritional supplements for humans and animals, veterinary medicines, and animal grooming products; blood glucose meters; and injection systems for diagnostic procedures. The companys Crop Protection segment provides fungicides, herbicides, insecticides, and seed treatment products. Its Environmental Science segment offers products for the green industry, garden care, non-agricultural pest, and weed control, as well as seeds and plant traits. The companys MaterialScience segment provides materials in the field of polyurethanes, polycarbonates, coating and adhesive raw materials, and functional films; inorganic basic chemicals, such as chlorine, sodium hydroxide solution, hydrogen, hydrochloric acid, and nitric acid; and polyurethane raw materials, polyurethane systems, and polycarbonates. The company also provides services in the areas of information technology infrastructure and applications, procurement and logistics, human resources and management services, and finance and accounting; technology services, including process development and in process and plant engineering, construction, and optimization; and services for the chemical industry comprising utility supply, waste management, infrastructure, safety, security, analytics, and vocational training. It has a strategic alliance with OncoMed Pharmaceuticals, Inc. to research, develop, and market novel therapeutics to control cancer stem cells. Bayer AG was founded in 1863 and is headquartered in Leverkusen, Germany.

Bayer AG (BAYZF) Stock Key Statistics Research and Analysis as of August 24, 2019

Mutual Funds with Bayer AG (BAYZF) Stock in its top 10 holdings

FundCategoryBAYZF Holding Percentage
American Beacon Intl Equity InstlForeign Large Value1.84%
Columbia European Equity BEurope Stock2.95%
American Beacon Intl Equity AForeign Large Value1.84%
Artisan International InvestorForeign Large Growth4.83%
Columbia European Equity AEurope Stock2.95%

ETFs with Bayer AG (BAYZF) Stock in its top 10 holdings

Latest Market News on Bayer AG (BAYZF)

Click here to find the latest news on Bayer AG (BAYZF)

Looking for Market Opportunties?

Today's Most Active Stocks
Today's Biggest Price % Gainers
Today's Biggest Price % Losers
Today's Unusual Rising Volume Stocks
Today's Unusual Falling Volume Stocks
Research Reports
Earning Calendar
ETF Center